HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 268 filers reported holding HAEMONETICS CORP in Q3 2020. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $109,915 | -2.7% | 1,227 | -7.5% | 0.00% | 0.0% |
| Q2 2023 | $112,981 | +102610.0% | 1,327 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $110 | +5.8% | 1,327 | +0.1% | 0.00% | 0.0% |
| Q4 2022 | $104 | -99.9% | 1,326 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $112,000 | +36.6% | 1,326 | +5.7% | 0.00% | 0.0% |
| Q2 2022 | $82,000 | +3.8% | 1,255 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $79,000 | +14.5% | 1,255 | -11.9% | 0.00% | 0.0% |
| Q4 2021 | $69,000 | -31.7% | 1,425 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $101,000 | +6.3% | 1,425 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $95,000 | +1257.1% | 1,425 | +2092.3% | 0.00% | – |
| Q1 2021 | $7,000 | -12.5% | 65 | 0.0% | 0.00% | – |
| Q4 2020 | $8,000 | +33.3% | 65 | 0.0% | 0.00% | – |
| Q3 2020 | $6,000 | 0.0% | 65 | 0.0% | 0.00% | – |
| Q2 2020 | $6,000 | -83.8% | 65 | -82.4% | 0.00% | – |
| Q1 2020 | $37,000 | -17.8% | 370 | -5.1% | 0.00% | – |
| Q4 2019 | $45,000 | -77.4% | 390 | -75.3% | 0.00% | -100.0% |
| Q3 2019 | $199,000 | +563.3% | 1,580 | +532.0% | 0.00% | – |
| Q2 2019 | $30,000 | +36.4% | 250 | 0.0% | 0.00% | – |
| Q1 2019 | $22,000 | -12.0% | 250 | 0.0% | 0.00% | – |
| Q4 2018 | $25,000 | -98.8% | 250 | -98.7% | 0.00% | -100.0% |
| Q3 2018 | $2,149,000 | +8854.2% | 18,755 | +6846.3% | 0.02% | – |
| Q2 2018 | $24,000 | +20.0% | 270 | 0.0% | 0.00% | – |
| Q1 2018 | $20,000 | +5.3% | 270 | -15.6% | 0.00% | – |
| Q4 2017 | $19,000 | +35.7% | 320 | 0.0% | 0.00% | – |
| Q3 2017 | $14,000 | +7.7% | 320 | 0.0% | 0.00% | – |
| Q2 2017 | $13,000 | 0.0% | 320 | 0.0% | 0.00% | – |
| Q1 2017 | $13,000 | -45.8% | 320 | -46.7% | 0.00% | – |
| Q4 2016 | $24,000 | +9.1% | 600 | 0.0% | 0.00% | – |
| Q3 2016 | $22,000 | +29.4% | 600 | 0.0% | 0.00% | – |
| Q2 2016 | $17,000 | -19.0% | 600 | 0.0% | 0.00% | – |
| Q1 2016 | $21,000 | – | 600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
| Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
| HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
| Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
| Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
| Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
| ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
| CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
| Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |